SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-18-043019
Filing Date
2018-02-14
Accepted
2018-02-13 18:00:56
Documents
3
Group Members
CASPER BREUMLENE SKOLE

Document Format Files

Seq Description Document Type Size
1 SC 13G d535395dsc13g.htm SC 13G 66353
2 EX-99.1 d535395dex991.htm EX-99.1 8816
3 EX-99.2 d535395dex992.htm EX-99.2 12064
  Complete submission text file 0001193125-18-043019.txt   88866
Mailing Address SCHERFIGSVEJ 7 COPENHAGEN G7 DK-2100
Business Address SCHERFIGSVEJ 7 COPENHAGEN G7 DK-2100 4540307375
Lundbeckfond Invest A/S (Filed by) CIK: 0001591046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Subject) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90168 | Film No.: 18605515
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences